finipil pro/elec

Manufacturer
Equibal, Inc.
Effective date
2025-12-17
Label type
HUMAN OTC DRUG LABEL
Version
15
Source
full-release
Hydrated at
2026-06-01 01:26:40

Label at a glance#

Productfinipil pro/elec
Active ingredientBENZETHONIUM CHLORIDE
Label structure13 sections

Dosage and administration

Directions Apply a small amount after Nufree®  or electric hair removal

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

DRUG FACTS

Active Ingredient

Benzethonium Chloride 0.2% w/w

Purpose

OTC - PURPOSE SECTION

Purpose

Antiseptic

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

Use(s)

INDICATIONS & USAGE SECTION

Uses(s)

  • first aid to help prevent bacterial contamination in minor cuts, scrapes, and burns.
  • cools, soothes, and moisturizes after hair removal.
  • recommended for repeated use.

Warnings Do not use in conjunction

WARNINGS SECTION

Warnings

For external use only
Do not use in conjunction
with products containing acids

Ask a doctor if

OTC - PREGNANCY OR BREAST FEEDING SECTION

Ask a doctor ifpregnant or breast feeding,

Stop use and ask a doctor if

OTC - STOP USE SECTION

Stop use and ask a doctor if

irritation and redness develop

Directions

DOSAGE & ADMINISTRATION SECTION

Directions

Apply a small amount after Nufree®  or electric hair removal

When using this product

OTC - WHEN USING SECTION

When using this product do not get into eyes.

If contact occurs, rinse eyes thoroughly with water.

Inactive ingredients

INACTIVE INGREDIENT SECTION

Inactive ingredients

Behentrimonium Methosulfate, Bisabolol, Butylene Glycol, Cetyl Alcohol, Chlorhexidine Gluconate, Dimethicone, Matricaria (Chamomile Recutita) Extract, Menthyl Lactate, Octyldodecanol, Phenoxyethanol, Polyquarternium-37, Stearic Acid, Water, Witch Hazel (Hamamelis Virginiana) Extract 

finipil pro/elec 3.6 ml

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

finipil®

antiseptic cream

for professional use only

soothes● cools● moisturizes

protects against infection

pro/elec

● ● ●

Noncomedogenic

3.6 ml.

DRUG FACTS

Active Ingredient                                             Purpose

Benzethonium Chloride 0.2% w/w           Antiseptic

Uses(s)

  • first aid to help prevent bacterial contamination in minor cuts, scrapes, and burns.
  • cools, soothes, and moisturizes after hair removal.
  • recommended for repeated use.

Warnings

For external use only

Ask a doctor ifpregnant or breast feeding.

When using this product do not get into eyes.

if contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if

irritation and redness develop

Do not use in conjunction

with products containing acids.

Keep out of reach of children

if swallowed, get medical help or contact a Poison Control Center right away.

Directions

Apply a small amount of Nufree® or electric hair removal.

Inactive Ingredients

Bethecrimium methosulfate, Bisabolol, Cetyle Alcohol, Chlorhexidine Gluconate, Dimethicone, Matricaria (Chamomile Recutital) Extract, Menthyl Lactate, Octylodecanoil, Phenoxyethanol, Phenoxyethanol, Polyquaterniuim-37, Stearic Acid, Water, Witch Hazel (Hamamelis Virginiana) Extract

Equibal labs                                        www.nufree.com

Made in U.S.A.                                  800-247-2405

not tested on animals                     patent# 8,603,550

Equibal finipil elecpro1 LabelEquibal finipil elecpro1 LabelEquibal finipil elecpro2 labelEquibal finipil elecpro2 label

finipil pro /elec 236 ml

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

finipil®

antiseptic cream

pro/elec

soothes● cools● moisturizes

protects against infection

Noncomedogenic

for professional use only

8 fl oz 236 ml

DRUG FACTS

Active Ingredient                                             Purpose

Benzethonium Chloride 0.2% w/w           Antiseptic

Uses(s)

  • first aid to help prevent bacterial contamination in minor cuts, scrapes, and burns.
  • cools, soothes, and moisturizes after hair removal.
  • recommended for repeated use.

Warnings

For external use only

Ask a doctor ifpregnant or breast feeding.

When using this product do not get into eyes.

if contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if

irritation and redness develop

Do not use in conjunction

with products containing acids.

Keep out of reach of children

if swallowed, get medical help or contact a Poison Control Center right away.

Directions

Apply a small amount of Nufree® or electric hair removal.

Inactive Ingredients

Bethecrimium methosulfate, Bisabolol, Cetyle Alcohol, Chlorhexidine Gluconate, Dimethicone, Matricaria (Chamomile Recutital) Extract, Menthyl Lactate, Octylodecanoil, Phenoxyethanol, Phenoxyethanol, Polyquaterniuim-37, Stearic Acid, Water, Witch Hazel (Hamamelis Virginiana) Extract

equibal labs

800-247-2405

nufree.com

Made in U.S.A.                                 

not tested on animals

patent# 8,603,550

finipil proelec 236 mlfinipil proelec 236 ml

finipil pro /elec 75 ml

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

finipil®

antiseptic cream

pro/elec

soothes ● cools ● moisturizes

protects against infection

Noncomedogenic

for professional use only

2.5 fl oz 75 ml

DRUG FACTS

Active Ingredient Purpose

Benzethonium Chloride 0.2% w/w Antiseptic

Uses(s)

first aid to help prevent bacterial contamination in minor cuts, scrapes, and burns.
cools, soothes, and moisturizes after hair removal.
recommended for repeated use.

Warnings

For external use only

Ask a doctor if pregnant or breast feeding.

When using this product do not get into eyes.

if contact occurs, rinse eyes thoroughly with water.

Stop use and ask a doctor if

irritation and redness develop

Do not use in conjunction

with products containing acids.

Keep out of reach of children

if swallowed, get medical help or contact a Poison Control Center right away.

Directions

Apply a small amount of Nufree® or electric hair removal.

Inactive Ingredients

Bethecrimium methosulfate, Bisabolol, Cetyle Alcohol, Chlorhexidine Gluconate, Dimethicone, Matricaria (Chamomile Recutital) Extract, Menthyl Lactate, Octylodecanoil, Phenoxyethanol, Phenoxyethanol, Polyquaterniuim-37, Stearic Acid, Water, Witch Hazel (Hamamelis Virginiana) Extract

equibal labs

800-247-2405

nufree.com

Made in U.S.A.

not tested on animals

patent# 8,603,550

finipil proelec 75 mlfinipil proelec 75 ml

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6c13b22c-b3ba-4127-b768-0132dd5ab0d1Product name120230829
bb6d6c68-649d-4e6d-a1f6-603d969c8f68Product name120160303

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53228-001-01finipil pro/elec75 mL in 1 TUBECREAM7515
53228-001-02finipil pro/elec3.6 mL in 1 PACKETCREAM3.615
53228-001-03finipil pro/elec236 mL in 1 BOTTLE, PUMPCREAM23615

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
BENZETHONIUM CHLORIDEACTIVE INGREDIENTPH41D057441
BENZETHONIUMACTIVE MOIETY1VU15B70BP1
BEHENTRIMONIUM METHOSULFATEINACTIVE INGREDIENT5SHP745C611
BUTYLENE GLYCOLINACTIVE INGREDIENT3XUS85K0RA1
CETYL ALCOHOLINACTIVE INGREDIENT936JST6JCN1
CHLORHEXIDINE GLUCONATEINACTIVE INGREDIENTMOR84MUD8E1
DIMETHICONEINACTIVE INGREDIENT92RU3N3Y1O1
HAMAMELIS VIRGINIANA TOPINACTIVE INGREDIENTUDA30A2JJY1
LEVOMENOLINACTIVE INGREDIENT24WE03BX2T1
MATRICARIA RECUTITAINACTIVE INGREDIENTG0R4UBI2ZZ1
MENTHYL LACTATE, (-)-INACTIVE INGREDIENT2BF9E65L7I1
OCTYLDODECANOLINACTIVE INGREDIENT461N1O614Y1
PHENOXYETHANOLINACTIVE INGREDIENTHIE492ZZ3T1
POLYQUATERNIUM-37 (25000 MPA.S)INACTIVE INGREDIENT31L31U82851
STEARIC ACIDINACTIVE INGREDIENT4ELV7Z65AP1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 17 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
53228-00153228-001-01, 53228-001-02, 53228-001-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 20 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
OCTYLDODECANOLOCTYLDODECANOL461N1O614YCREAM / TOPICAL160 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNCREAM / TOPICAL1280 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
BUTYLENE GLYCOLBUTYLENE GLYCOL3XUS85K0RASYSTEM / TOPICAL1400 mgExact identifier — unii+route
4 equally ranked IID candidates
PHENOXYETHANOLPHENOXYETHANOLHIE492ZZ3TCREAM / TOPICAL57 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APCREAM / TOPICAL190 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNCREAM / TOPICAL1280 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
OCTYLDODECANOLOCTYLDODECANOL461N1O614YCREAM / TOPICAL160 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
OCTYLDODECANOLOCTYLDODECANOL461N1O614YCREAM / TOPICAL160 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNCREAM / TOPICAL1280 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
PHENOXYETHANOLPHENOXYETHANOLHIE492ZZ3TCREAM / TOPICAL57 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
PHENOXYETHANOLPHENOXYETHANOLHIE492ZZ3TCREAM / TOPICAL57 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APCREAM / TOPICAL190 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APCREAM / TOPICAL190 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
BUTYLENE GLYCOLBUTYLENE GLYCOL3XUS85K0RASYSTEM / TOPICAL1400 mgExact identifier — unii+route
4 equally ranked IID candidates
OCTYLDODECANOLOCTYLDODECANOL461N1O614YCREAM / TOPICAL160 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
BUTYLENE GLYCOLBUTYLENE GLYCOL3XUS85K0RASYSTEM / TOPICAL1400 mgExact identifier — unii+route
4 equally ranked IID candidates
BUTYLENE GLYCOLBUTYLENE GLYCOL3XUS85K0RASYSTEM / TOPICAL1400 mgExact identifier — unii+route
4 equally ranked IID candidates
STEARIC ACIDSTEARIC ACID4ELV7Z65APCREAM / TOPICAL190 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
CETYL ALCOHOLCETYL ALCOHOL936JST6JCNCREAM / TOPICAL1280 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates
PHENOXYETHANOLPHENOXYETHANOLHIE492ZZ3TCREAM / TOPICAL57 mgExact identifier — unii+route+dosage form
4 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
finipil pro/elecBENZETHONIUM CHLORIDEEquibal, Inc.f68aa5db-7a4e-410f-8159-3356d9407d312025-12-17WarningsExact identifier
ndc (package): 53228-001-03
ndc (package): 53228-001-01
ndc (package): 53228-001-02
ndc (product): 53228-001
ndc11 (package): 53228000103
ndc11 (package): 53228000102
ndc11 (package): 53228000101
spl id: 46332a46-c1c3-3043-e063-6394a90ae90f
spl set id: f68aa5db-7a4e-410f-8159-3356d9407d31

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.